Michael Cella

Person
Mentions
186
Relationships
12
Events
1
Documents
89

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
12 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Cowen
Employee
18 Very Strong
38
View
person Cowen
Employment affiliation
11 Very Strong
19
View
person Cowen
Professional
7
3
View
person Cowen
Employment internal distribution
7
2
View
person Cowen
Employment internal
6
2
View
person Cowen
Client
6
1
View
person Cowen
Professional employment
6
2
View
person Cowen
Employment
5
1
View
person Cowen and Company
Employment affiliation
5
1
View
person Cowen and Company, LLC
Employee
5
1
View
person Cowen
Employment recipient
5
1
View
person Cowen and Company
Employee
1
1
View
Date Event Type Description Location Actions
2019-02-25 N/A Publication of Cowen Collaborative Insights report. N/A View

HOUSE_OVERSIGHT_024865.jpg

This document is page 49 of a financial research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the market potential for CBD-infused food and confections in the U.S., projecting sales could surpass $400 million by 2020. The document contains charts and sensitivity analyses regarding market share and revenue growth. It bears the Bates stamp HOUSE_OVERSIGHT_024865, indicating it was part of a document production for the House Oversight Committee, though the specific content is strictly market research unrelated to specific individuals.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024864.jpg

This document is page 48 of a Cowen Collaborative Insights financial research report dated February 25, 2019. It analyzes product offerings and packaging from CBD companies 'Lord Jones' and 'Charlotte's Web' (CWEB), specifically lotions, oils, and balms. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was gathered as evidence during a congressional investigation, likely related to financial oversight, though no direct mention of Jeffrey Epstein appears on this specific page.

Financial research report / market analysis page
2025-11-19

HOUSE_OVERSIGHT_024862.jpg

This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024860.jpg

A page from a Cowen financial research report dated February 25, 2019, analyzing the U.S. Beauty industry and specifically projecting growth for CBD beauty products. It includes charts forecasting sales growth through 2020. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though the page itself contains no direct references to Jeffrey Epstein or illicit activity.

Financial research report
2025-11-19

HOUSE_OVERSIGHT_024859.jpg

This document is page 43 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually analyzes four CBD/hemp-infused products: Recess sparkling water, Sprig soda, Reliva recovery shots, and Willie's Remedy coffee. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it is part of a larger collection of documents subpoenaed or reviewed by the House Oversight Committee.

Market research report / financial analysis slide
2025-11-19

HOUSE_OVERSIGHT_024858.jpg

A page from a Cowen market research report dated February 25, 2019, analyzing the CBD beverage market. The document includes data on price segmentation of various CBD beverage brands and demographic statistics regarding consumer usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024857.jpg

This document is page 41 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the beer market. It focuses on the growth of Hard Seltzer and the potential revenue opportunities for CBD-infused beer, projecting market values up to 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024857) and is digitally watermarked for Michael Cella.

Financial research report
2025-11-19

HOUSE_OVERSIGHT_024855.jpg

This document is page 39 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the market potential for CBD-infused bottled water in the U.S., utilizing Google Trends and Nielsen sales data to project revenue growth through 2020. The document bears the Bates stamp HOUSE_OVERSIGHT_024855 and is watermarked for Michael Cella at Cowen.

Market research report
2025-11-19

HOUSE_OVERSIGHT_024853.jpg

This document is page 37 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually compares four CBD topical products from companies Mary's Medicinals, Curaleaf, Highline, and Reliva, noting packaging and pricing strategies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a Congressional investigation.

Market research report / equity research page
2025-11-19

HOUSE_OVERSIGHT_024852.jpg

This document is page 36 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the CBD topical market, detailing price segments (Super Premium to Value) and consumer demographics (age, gender, income). While the document bears a 'HOUSE_OVERSIGHT_024852' Bates stamp, indicating it is part of a government investigation (potentially related to the Epstein case files via subpoenaed financial records), the content on this specific page is purely market research regarding CBD products and does not explicitly mention Epstein or his associates.

Market research report / house oversight document
2025-11-19

HOUSE_OVERSIGHT_024851.jpg

This document is page 35 of a financial research report produced by Cowen on February 25, 2019, analyzing the U.S. CBD market, specifically focusing on 'Topicals.' The report projects the topical CBD market to grow to $1.5 billion by 2020. The document bears a 'HOUSE_OVERSIGHT_024851' Bates stamp, indicating it was obtained during a House Oversight Committee investigation, though the content of this specific page is purely financial market analysis and does not explicitly mention Jeffrey Epstein.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024850.jpg

This document is page 34 of a Cowen 'Collaborative Insights' market research report dated February 25, 2019. It analyzes the packaging and pricing of CBD gummy products from four different companies: CV Sciences, Green Roads, Highline Wellness, and cbdMD. The document bears a 'HOUSE_OVERSIGHT_024850' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content appears to be standard equity research unrelated to criminal activity.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024848.jpg

This document is page 32 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the packaging and market positioning of four CBD/Hemp capsule brands: Mary's Medicinals, Charlotte's Web, Elixinol, and Lazarus Naturals. The page contains the Bates stamp HOUSE_OVERSIGHT_024848, indicating it was part of a document production to the House Oversight Committee, though the visible content focuses solely on commercial cannabis products.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024847.jpg

This document is page 31 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. It analyzes the pricing segments of various CBD capsule brands and presents demographic data (gender, age, income) regarding CBD capsule usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely as part of a larger cache of financial or corporate records.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024846.jpg

This document is page 30 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the packaging and market positioning of four CBD brands: Lord Jones, CV Sciences (Plus CBD Oil), Papa & Barkley, and Reliva. The document bears the Bates stamp HOUSE_OVERSIGHT_024846, indicating it was obtained during a US House Oversight Committee investigation, though the specific page content relates strictly to commercial CBD products and contains no direct mention of Jeffrey Epstein.

Market research report / financial analyst report
2025-11-19

HOUSE_OVERSIGHT_024845.jpg

This document is page 29 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019, analyzing the CBD tincture market. It presents data on price segmentation among competitors (such as Lord Jones and Lazarus) and consumer demographics regarding tincture usage. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024845', indicating it was obtained during a House Oversight Committee investigation, likely as part of a larger cache of documents from a financial institution, though the content itself is strictly market research.

Market research report / financial analysis
2025-11-19

HOUSE_OVERSIGHT_024844.jpg

This document is page 28 of a financial research report produced by Cowen on February 25, 2019, analyzing the Nutraceuticals market. It specifically focuses on U.S. CBD sales projections following the 2018 Farm Bill, estimating $2.4 billion in revenue by 2020. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024844), suggesting it was part of a subpoena or discovery process involving Cowen.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024843.jpg

This document is page 27 of a Cowen Collaborative Insights financial report dated February 25, 2019. The content is a market analysis of the CBD (Cannabidiol) industry, breaking down price per milligram across various product categories such as tinctures, gummies, and beauty products. While the content itself is strictly financial research regarding consumer staples, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024843', indicating it was part of a document production for a US House Oversight Committee investigation.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024842.jpg

This document is page 26 of a market research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the CBD and Hemp industry through the lens of Instagram metrics (followers, posts, likes) for January 2019, comparing emerging brands like CBDFX and Lord Jones against established public companies. While the document bears a 'HOUSE_OVERSIGHT_024842' stamp, suggesting it was part of a document production for a congressional investigation (potentially related to financial probes involving Epstein or Deutsche Bank), the content itself is strictly commercial market analysis with no direct mention of Jeffrey Epstein.

Market research report / investment bank analysis
2025-11-19

HOUSE_OVERSIGHT_024841.jpg

This document is page 25 of a market research report by Cowen Collaborative Insights, dated February 25, 2019. It analyzes the growth of Hemp Oil products on Amazon (increasing from ~5,000 to >20,000 between 2013 and 2019) and provides demographic data on CBD supplement usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation, though the content itself is strictly market data regarding CBD and does not mention Epstein directly.

Market research report
2025-11-19

HOUSE_OVERSIGHT_024840.jpg

This document is page 24 of a Cowen Collaborative Insights research report dated February 25, 2019, analyzing the U.S. CBD market. It presents data suggesting the market size is approaching $2 billion based on consumer surveys and increasing Google search trends for CBD products like gummies, creams, and oils. The document bears a House Oversight Bates stamp (024840), indicating it was part of a document production to Congress, though no direct mention of Jeffrey Epstein appears on this specific page.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024839.jpg

This document is page 23 of a financial research report produced by Cowen regarding the 'Separations Technology and Market' (Chromatography). It details the technical differences between Liquid Chromatography (LC) and Gas Chromatography (GC), their usage with Mass Spectrometry, and provides market estimates and share data for 2014-2018. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced during a congressional investigation, but the text itself contains technical scientific market data and no direct references to Jeffrey Epstein.

Financial research report / market analysis
2025-11-19

HOUSE_OVERSIGHT_024837.jpg

This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.

Financial research report / investment analysis
2025-11-19

HOUSE_OVERSIGHT_024836.jpg

This document is page 20 of a Cowen 'Collaborative Insights' financial research report dated February 25, 2019. It details the scientific process of biosynthetic cannabinoid production via fermentation and highlights a specific February 2019 business deal where Amyris signed a partnership valued at up to $255 million with an 'undisclosed partner.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.

Financial research report / investment analysis
2025-11-19

HOUSE_OVERSIGHT_024835.jpg

This document is page 19 of a Cowen 'Collaborative Insights' report dated February 25, 2019. It details the industry landscape for synthetic biology cannabinoid production, listing specific companies such as Ginkgo Bioworks and Amyris with brief descriptions of their technologies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.

Financial research report / industry analysis
2025-11-19
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
28
Total
28

Additional Applications / Implications - Epilepsy & Psych...

From: Cowen
To: Michael Cella

Analysis of cannabinoid-based drugs, specifically GW's Epidiolex and Zynerba's ZYN002, including clinical trial data.

Report distribution
2019-02-25

Cowen Collaborative Insights

From: Cowen Research
To: Michael Cella

Research report distribution intended for michael.cella@cowen.com

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis of corn, soybeans, and hemp production economics.

Report distribution
2019-02-25

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and Epidiolex efficacy/safety data.

Report distribution
2019-02-25

Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and CBD clinical trials.

Report distribution
2019-02-25

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding CBD/Cannabis regulations in Europe.

Report distribution
2019-02-25

Consumer Products Market Sizing (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Market research report regarding CBD usage statistics and market sizing.

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Financial analysis of the U.S. Beauty and CBD Beauty markets.

Report distribution
2019-02-25

Collaborative Insights: Vapor

From: Cowen
To: Michael Cella

Market analysis of CBD vapor and e-cigarette sales projections.

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule providers distributed to michael.cella@cowen.com

Report distribution
2019-02-25

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market analysis of CBD confection and bar products, including price segmentation.

Report distribution
2019-02-25

Valuation Methodology and Risks

From: Cowen
To: Michael Cella

Investment report distribution restricted to michael.cella@cowen.com

Report distribution
2019-02-25

Cowen Collaborative Insights Report

From: Cowen
To: Michael Cella

Analysis of Epidiolex drug trials and investor sentiment regarding efficacy with/without clobazam.

Report distribution
2019-02-25

Collaborative Insights

From: Cowen
To: Michael Cella

Financial analysis of cannabis and tobacco companies.

Report distribution
2019-02-25

Cowen Collaborative Insights - CBD Market Analysis

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule pricing and demographic usage statistics.

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis of CBD gummy pricing and packaging.

Report distribution
2019-02-25

Report Distribution

From: Cowen
To: Michael Cella

This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.

Report distribution
2019-02-25

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report regarding cannabis market partnerships.

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry report on Synthetic Biology Cannabinoid Companies.

Report distribution
2019-02-25

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding hemp and CBD in textiles.

Report distribution
2019-02-25

Collaborative Insights - Topicals

From: Cowen
To: Michael Cella

Markey analysis of CBD topicals distributed to internal employee.

Report distribution
2019-02-25

Global CBD Landscape (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Analysis of international drug conventions and WHO recommendations regarding CBD regulation.

Report distribution
2019-02-25

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry analysis regarding CBD-infused textiles and partnerships.

Report distribution
2019-02-25

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity